{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:32:22Z","timestamp":1772519542296,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["T32 DK007028"],"award-info":[{"award-number":["T32 DK007028"]}]},{"name":"NIH","award":["K23DK113220"],"award-info":[{"award-number":["K23DK113220"]}]},{"name":"NIH","award":["K24HL092902"],"award-info":[{"award-number":["K24HL092902"]}]},{"DOI":"10.13039\/100003769","name":"Foundation for Women's Wellness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00737-024-01532-3","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T01:39:13Z","timestamp":1732671553000},"page":"771-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroactive steroid levels are elevated in the follicular phase and predict premenstrual depression and anxiety symptom severity in women with menstrually related mood disorder"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-644X","authenticated-orcid":false,"given":"Allison","family":"Kimball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Bourassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Chicote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu V.","family":"Gerweck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Dichtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"1532_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Washington, D.C","edition":"5"},{"key":"1532_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0006-8993(97)00455-1","volume":"764","author":"M Bixo","year":"1997","unstructured":"Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T (1997) Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 764:173\u2013178","journal-title":"Brain Res"},{"key":"1532_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psyneuen.2017.02.031","volume":"80","author":"M Bixo","year":"2017","unstructured":"Bixo M, Ekberg K, Poromaa IS, Hirschberg AL, Jonasson AF, Andreen L, Timby E, Wulff M, Ehrenborg A, Backstrom T (2017) Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial. Psychoneuroendocrinology 80:46\u201355","journal-title":"Psychoneuroendocrinology"},{"key":"1532_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1176\/appi.ajp.157.6.924","volume":"157","author":"M Bloch","year":"2000","unstructured":"Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157:924\u2013930","journal-title":"Am J Psychiatry"},{"key":"1532_CR5","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1046\/j.1471-4159.1997.68062412.x","volume":"68","author":"AE Bullock","year":"1997","unstructured":"Bullock AE, Clark AL, Grady SR, Robinson SF, Slobe BS, Marks MJ, Collins AC (1997) Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem 68:2412\u20132423","journal-title":"J Neurochem"},{"key":"1532_CR6","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1523\/JNEUROSCI.15-06-04641.1995","volume":"15","author":"DL Cheney","year":"1995","unstructured":"Cheney DL, Uzunov D, Costa E, Guidotti A (1995) Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci 15:4641\u20134650","journal-title":"J Neurosci"},{"key":"1532_CR7","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/npp.2017.269","volume":"43","author":"LE Dichtel","year":"2018","unstructured":"Dichtel LE, Lawson EA, Schorr M, Meenaghan E, Paskal ML, Eddy KT, Pinna G, Nelson M, Rasmusson AM, Klibanski A, Miller KK (2018) Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum. Neuropsychopharmacology 43:1436\u20131444","journal-title":"Neuropsychopharmacology"},{"key":"1532_CR8","doi-asserted-by":"crossref","unstructured":"Dichtel LE, Nyer M, Dording C, Fisher LB, Cusin C, Shapero BG, Pedrelli P, Kimball AS, Rao EM, Mischoulon D, Fava M, Miller KK (2020) Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study. J Clin Psychiatry 81(4)","DOI":"10.4088\/JCP.19m12887"},{"key":"1532_CR9","first-page":"106","volume":"8","author":"ASK Direkvand-Moghadam","year":"2014","unstructured":"Direkvand-Moghadam ASK, Delpisheh A, Kaikhavandi S (2014) Epidemiology of Premenstrual Syndrome (PMS)-A Systematic Review and Meta-Analysis Study. J Clin Diagn Res 8:106\u2013109","journal-title":"J Clin Diagn Res"},{"key":"1532_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1176\/appi.ajp.2016.15121510","volume":"174","author":"TA Eisenlohr-Moul","year":"2017","unstructured":"Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, Dawson DN, Surana P, Johnson JL, Rubinow DR (2017) Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS). Am J Psychiatry 174:51\u201359","journal-title":"Am J Psychiatry"},{"key":"1532_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","volume":"9","author":"J Endicott","year":"2006","unstructured":"Endicott J, Nee J, Harrison W (2006) Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 9:41\u201349","journal-title":"Arch Womens Ment Health"},{"key":"1532_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.neuroscience.2005.07.007","volume":"138","author":"D Eser","year":"2006","unstructured":"Eser D, Romeo E, Baghai TC, di Michele F, Schule C, Pasini A, Zwanzger P, Padberg F, Rupprecht R (2006) Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138:1041\u20131048","journal-title":"Neuroscience"},{"key":"1532_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0028-3908(01)00187-3","volume":"42","author":"P Follesa","year":"2002","unstructured":"Follesa P, Porcu P, Sogliano C, Cinus M, Biggio F, Mancuso L, Mostallino MC, Paoletti AM, Purdy RH, Biggio G, Concas A (2002) Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42:325\u2013336","journal-title":"Neuropharmacology"},{"key":"1532_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0006-3223(00)01044-1","volume":"49","author":"SS Girdler","year":"2001","unstructured":"Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788\u2013797","journal-title":"Biol Psychiatry"},{"key":"1532_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0006-8993(01)02565-3","volume":"910","author":"M Gulinello","year":"2001","unstructured":"Gulinello M, Gong QH, Li X, Smith SS (2001) Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res 910:55\u201366","journal-title":"Brain Res"},{"issue":"Suppl 3","key":"1532_CR16","first-page":"1","volume":"28","author":"U Halbreich","year":"2003","unstructured":"Halbreich U, Borenstein J, Pearlstein T, Kahn LS (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD). Psychoneuroendocrinology 28(Suppl 3):1\u201323","journal-title":"Psychoneuroendocrinology"},{"key":"1532_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/biom13040652","volume":"13","author":"A Hamidovic","year":"2023","unstructured":"Hamidovic A, Davis J, Soumare F, Datta A, Naveed A (2023) Trajectories of Allopregnanolone and Allopregnanolone to Progesterone Ratio across the Six Subphases of Menstrual Cycle. Biomolecules 13:652","journal-title":"Biomolecules"},{"issue":"10","key":"1532_CR18","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1038\/s41380-024-02566-w","volume":"29","author":"A Hamidovic","year":"2024","unstructured":"Hamidovic A, Mumford S, Schisterman E, Davis J, Soumare F (2024) Neuroactive steroid hormone trajectories across the menstrual cycle in premenstrual dysphoric disorder (PMDD): the PHASE study. Mol Psychiatry 29(10):3056\u20133063","journal-title":"Mol Psychiatry"},{"key":"1532_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2020.100213","volume":"12","author":"L Hantsoo","year":"2020","unstructured":"Hantsoo L, Epperson CN (2020) Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress 12:100213","journal-title":"Neurobiol Stress"},{"key":"1532_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","volume":"116","author":"AM Hosie","year":"2007","unstructured":"Hosie AM, Wilkins ME, Smart TG (2007) Neurosteroid binding sites on GABA(A) receptors. Pharmacol Ther 116:7\u201319","journal-title":"Pharmacol Ther"},{"key":"1532_CR21","doi-asserted-by":"publisher","first-page":"9497","DOI":"10.1007\/s00216-013-7391-2","volume":"405","author":"W Jin","year":"2013","unstructured":"Jin W, Jarvis M, Star-Weinstock M, Altemus M (2013) A sensitive and selective LC-differential mobility-mass spectrometric analysis of allopregnanolone and pregnanolone in human plasma. Anal Bioanal Chem 405:9497\u20139508","journal-title":"Anal Bioanal Chem"},{"key":"1532_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuroscience.2011.05.054","volume":"191","author":"R Kancheva","year":"2011","unstructured":"Kancheva R, Hill M, Novak Z, Chrastina J, Kancheva L, Starka L (2011) Neuroactive steroids in periphery and cerebrospinal fluid. Neuroscience 191:22\u201327","journal-title":"Neuroscience"},{"key":"1532_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsbmb.2009.12.006","volume":"119","author":"R Kancheva","year":"2010","unstructured":"Kancheva R, Hill M, Novak Z, Chrastina J, Velikova M, Kancheva L, Riha I, Starka L (2010) Peripheral neuroactive steroids may be as good as the steroids in the cerebrospinal fluid for the diagnostics of CNS disturbances. J Steroid Biochem Mol Biol 119:35\u201344","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1532_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","volume":"390","author":"S Kanes","year":"2017","unstructured":"Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S (2017) Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 390:480\u2013489","journal-title":"Lancet"},{"key":"1532_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104512","volume":"112","author":"A Kimball","year":"2020","unstructured":"Kimball A, Dichtel LE, Nyer MB, Mischoulon D, Fisher LB, Cusin C, Dording CM, Trinh NH, Yeung A, Haines MS, Sung JC, Pinna G, Rasmusson AM, Carpenter LL, Fava M, Klibanski A, Miller KK (2020) The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause. Psychoneuroendocrinology 112:104512","journal-title":"Psychoneuroendocrinology"},{"key":"1532_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-5559-2","volume-title":"Neurosteroids and the Nervous System","author":"SR King","year":"2013","unstructured":"King SR (2013) Neurosteroids and the Nervous System. Springer-Verlag, New York, New York NY"},{"key":"1532_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","volume":"59","author":"J Maguire","year":"2008","unstructured":"Maguire J, Mody I (2008) GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 59:207\u2013213","journal-title":"Neuron"},{"key":"1532_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/npp.2015.246","volume":"41","author":"PE Martinez","year":"2016","unstructured":"Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ (2016) 5alpha-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology 41:1093\u20131102","journal-title":"Neuropsychopharmacology"},{"key":"1532_CR29","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","volume":"31","author":"CE Marx","year":"2006","unstructured":"Marx CE, Stevens RD, Shampine LJ, Uzunova V, Trost WT, Butterfield MI, Massing MW, Hamer RM, Morrow AL, Lieberman JA (2006) Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31:1249\u20131263","journal-title":"Neuropsychopharmacology"},{"key":"1532_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/eje.0.1420269","volume":"142","author":"P Monteleone","year":"2000","unstructured":"Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142:269\u2013273","journal-title":"Eur J Endocrinol"},{"key":"1532_CR31","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.psyneuen.2005.04.016","volume":"30","author":"S Nyberg","year":"2005","unstructured":"Nyberg S, Andersson A, Zingmark E, Wahlstrom G, Backstrom T, Sundstrom-Poromaa I (2005) The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls. Psychoneuroendocrinology 30:892\u2013901","journal-title":"Psychoneuroendocrinology"},{"key":"1532_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0006-8993(99)01381-5","volume":"830","author":"M Park-Chung","year":"1999","unstructured":"Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH (1999) Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res 830:72\u201387","journal-title":"Brain Res"},{"key":"1532_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","volume":"90","author":"AJ Rapkin","year":"1997","unstructured":"Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709\u2013714","journal-title":"Obstet Gynecol"},{"key":"1532_CR34","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.biopsych.2006.03.026","volume":"60","author":"AM Rasmusson","year":"2006","unstructured":"Rasmusson AM, Pinna G, Paliwal P, Weisman D, Gottschalk C, Charney D, Krystal J, Guidotti A (2006) Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry 60:704\u2013713","journal-title":"Biol Psychiatry"},{"key":"1532_CR35","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1176\/ajp.155.7.910","volume":"155","author":"E Romeo","year":"1998","unstructured":"Romeo E, Strohle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910\u2013913","journal-title":"Am J Psychiatry"},{"key":"1532_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB (2003) The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54:573\u2013583","journal-title":"Biol Psychiatry"},{"key":"1532_CR37","first-page":"1256","volume":"79","author":"PJ Schmidt","year":"1994","unstructured":"Schmidt PJ, Purdy RH, Moore PH Jr, Paul SM, Rubinow DR (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79:1256\u20131260","journal-title":"J Clin Endocrinol Metab"},{"key":"1532_CR38","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20): 22\u201333;quiz 34\u201357"},{"key":"1532_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097","journal-title":"Arch Intern Med"},{"key":"1532_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","volume":"45","author":"A Strohle","year":"1999","unstructured":"Strohle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F, Holsboer F, Rupprecht R (1999) Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45:274\u2013277","journal-title":"Biol Psychiatry"},{"key":"1532_CR41","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00213-016-4258-1","volume":"233","author":"E Timby","year":"2016","unstructured":"Timby E, Backstrom T, Nyberg S, Stenlund H, Wihlback AC, Bixo M (2016) Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study. Psychopharmacology 233:2109\u20132117","journal-title":"Psychopharmacology"},{"key":"1532_CR42","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","volume":"95","author":"V Uzunova","year":"1998","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95:3239\u20133244","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1532_CR43","first-page":"1076","volume":"81","author":"M Wang","year":"1996","unstructured":"Wang M, Seippel L, Purdy RH, Backstrom T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81:1076\u20131082","journal-title":"J Clin Endocrinol Metab"},{"key":"1532_CR44","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/mend.12.9.0163","volume":"12","author":"CH Wetzel","year":"1998","unstructured":"Wetzel CH, Hermann B, Behl C, Pestel E, Rammes G, Zieglg\u00e4nsberger W, Holsboer F, Rupprecht R (1998) Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol 12:1441\u20131451","journal-title":"Mol Endocrinol"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-024-01532-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-024-01532-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-024-01532-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:02:14Z","timestamp":1757721734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-024-01532-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1007\/s00737-024-01532-3","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LED has received study medication from Pfizer, research support from Perspectum Ltd. and research support from Lumos Pharma, all per investigator-initiated request, and additional research support from Recordati and Novo Nordisk. She has equity in Marea Therapeutics and is a consultant for Lumos Pharma. She was\u00a0a fellow at Third Rock Ventures through the Mass General Brigham\u2019s Innovation Fellows Program but remained a full-time employee of Mass General Brigham during the course of this educational program (10\/1\/2022\u20139\/30\/2024). KKM has received study medication and investigator-initiated research grants from Amgen and has equity in Bristol-Myers Squibb (BMS), General Electric, Boston Scientific, and Becton Dickinson. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}